Work
From divestment to market leader
The challenge: Following its acquisition by EMK Capital, this newly independent infrastructure giant required more than just a fresh coat of paint – it required a new strategic narrative. The leadership team needed to bridge the gap between private equity’s ESG-focused investment thesis and the brand’s day-to-day operational reality.
Multi-generational brand building
The challenge: YOYO, a direct-to-consumer skincare brand, required a complete “world-building” exercise from the ground up. The challenge was uniquely complex: we needed to create a brand that genuinely resonated as “cool” and aspirational for the 10–16-year-old “tween” market, while simultaneously communicating the premium quality, trust, and safety cues required by the parents actually purchasing the products.
Brand reinvention: scaling Aldevron for ambitious global growth
The challenge: Aldevron was eyeing ambitious global growth, but previous agencies had consistently failed to accurately translate their complex scientific capabilities. The brand needed a total reinvention that could cut through dense, highly technical information and deliver a clear, compelling narrative capable of driving volume sales and scaling the business.
Scaling from Startup to Global CDMO
The challenge: How does a sub-100-person drug discovery business successfully pivot into a 1,000+ employee global Cell and Gene Therapy CDMO? For Oxford Biomedica, the challenge was managing a massive growth trajectory and rapid physical expansion across the UK, France, and the US without diluting their core identity. As they scaled, they needed a way to keep their highly complex scientific narrative cohesive, compelling, and consistent across multiple international markets and a rapidly growing workforce.
Navigating a new vision
The challenge: Following the strategic sale of their commercial division, Nicox entered a period of major restructuring. The challenge was to redefine their corporate identity to reflect a new, leaner focus on R&D and ophthalmic innovation. They needed to signal stability and future-facing ambition to the market during a delicate phase of organizational change, ensuring that their internal culture and external reputation remained aligned.
Building a biomanufacturing pioneer from scratch for proven founders
The challenge: Following the monumental $9.6B acquisition of Aldevron, former Senior Executive James Brown partnered with two of the company’s visionary founders to launch a highly disruptive new venture: Agathos. Entering the complex biomanufacturing space with a transformational, ethics-driven approach, the challenge was to establish immediate commercial credibility and translate their highly technical science into a clear, compelling narrative that could capture market attention.
The sound of precision
The challenge: OxSonics is pioneering a revolutionary “ultrasound-enhanced” oncology platform – a sophisticated technology built on the principles of sonar that is inherently difficult to visualize for those outside the lab. To successfully engage clinical partners and the investment community, they needed to bridge the gap between dense acoustic physics and a compelling, premium brand story. The challenge was to simplify the narrative without stripping away the technical authority required in the oncology space.
Crafting a unified corporate story through strategic renaming
The challenge: When UK-listed Retroscreen needed to align its brand with an evolving vision, they faced a significant hurdle: their various scientific divisions were dense and highly complex. They required a partner capable of untangling these internal complexities to craft a unified corporate story and lead a complete renaming and rebranding initiative.
Building a New Reputation
The challenge: Formerly known as Pro Bono Bio, the company faced significant hurdles due to a problematic name and a damaged market reputation. Under the new leadership of CEO Biresh Roy (former FD of thinkerdoer client Verona Pharma) and COO/Co-founder Richard Garaway, the business required a clean slate to signal a radically improved era. The core challenge was twofold: resetting stakeholder perceptions and creating a cohesive brand story that united a diverse portfolio – from Direct-to-Consumer (DTC) products like Flexiseq to a complex development pipeline for Haemophilia A sufferers.
From animal ethics to medical ethics: repositioning for global human healthcare
The challenge: Australian business Animal Ethics had developed a revolutionary platform technology with the potential to transform human wound care. The core challenge was strategically repositioning their brand for a completely new global market. They needed to elevate their corporate narrative to support “Medi-Solfen” – a groundbreaking human therapy aimed at alleviating suffering, reducing blood loss, and improving recovery in open wounds. This required a sophisticated positioning that spoke to human healthcare markets while maintaining the strong heritage and credibility of their wildly successful veterinary product, Tri-Solfen.
Translating complex AI imaging into a cohesive global brand
The challenge: As a pioneer in AI-driven medical imaging, Median Technologies needed a brand ecosystem that could communicate their highly complex technology to a broad spectrum of global stakeholders – from clinical trial managers to institutional investors.
Redefining wealth for a new generation
The challenge: Killik & Co was a highly respected heritage stockbroker with a loyal, but aging, client base concentrated heavily in traditional South East England postcodes. To ensure long-term commercial vitality, the firm recognized the need for a strategic pivot. The challenge was to modernize the brand to attract a younger, more dynamic demographic and expand geographically, all without alienating the established clients who formed the foundation of their business.
Positioning groundbreaking science for next-stage investment
The challenge: Calviri possessed highly ambitious, world-changing oncology technology, but to secure their next crucial stage of growth, they needed to evolve their narrative. Backed by top-tier biotech investors Michael Chambers and John Ballantyne (founders of Aldevron), the company appointed a new CEO, Marc Wolff, to drive commercial scaling. The challenge was to transition the brand from a purely scientific, academic endeavor into a compelling, commercially viable asset that could confidently secure major institutional funding.
Engineering a cohesive brand framework for global infrastructure
The challenge: As a titan of the global infrastructure sector operating in a highly complex and heavily regulated market, Laing O’Rourke required a brand presence that matched the scale, precision, and rigor of their engineering. The challenge was multifaceted: they needed a unified brand architecture that could translate seamlessly across diverse, high-stakes touchpoint – from multi-million-pound technical bid submissions to corporate reporting and internal employee engagement.
Building a consumer-friendly retail health brand from scratch
The challenge: Novartis Vaccines needed to launch a pilot Direct-to-Consumer (DTC) brand for travel vaccines. The primary hurdle was taking highly regulated, dense epidemiological data – such as viral incubation periods and transmission vectors – and translating it into engaging, accessible, and consumer-friendly retail health information.
Navigating complex European regulations for a dual-audience digital launch
The challenge: Following VC GHO Capital’s acquisition of the commercial arm of Nicox, a brand-new entity needed to be established to sell physical medical products across the UK and five major European markets. The primary challenge was twofold: building a cohesive new brand identity from scratch, and executing a massive digital rollout that strictly adhered to the complex, highly nuanced medical and consumer regulations of six different countries.
Navigating the IPO journey: positioning, branding, and rebranding Circassia
The challenge: Circassia was preparing for a high-stakes UK IPO with the ambition of entering the market straight as a FTSE 250 company. To support this monumental move, they needed a foundational visual identity built from scratch. Alongside this, the critical hurdle was navigating the strict, highly sensitive financial and medical regulations governing corporate communications during an IPO period. The company needed a partner capable of building a world-class brand while expertly managing what could – and couldn’t – be said to potential investors without jeopardizing the listing.
Designing global trust for a novel infant innovation
The challenge: As the creator of a truly novel baby feeding system, Yoomi possessed a groundbreaking product with immense commercial potential. However, introducing an innovative infant care product to new international markets presents a unique hurdle: parents are an inherently cautious demographic. The challenge was to create a globally resonant brand and packaging system that could instantly communicate safety, premium quality, and intuitive design across diverse retail landscapes and languages.
From post-construction to premium concierge: crafting the club concierge experience
The challenge: When thinkerdoer purchased our London offices from the Berkeley Group, we were introduced to BOX – a trusted partner responsible for preparing high-end luxury apartments post-construction for buyer handovers. They initially needed a polished brand refresh to reflect the premium nature of their work. However, the challenge quickly expanded. The founder had a vision for a completely new, next-level concierge business designed to handle the intense lifestyle demands of busy London City professionals – from dry cleaning and groceries to receiving furniture and managing Airbnb rentals. They needed a brand built from scratch that would instantly resonate with this high-net-worth demographic.
Delivering an SEC-compliant digital presence for a US tech VC
The challenge: ePlanet, a prominent US technology venture capital firm, needed a digital update. As a financial entity, their primary hurdle wasn’t just aesthetics – it was strict regulatory adherence. They required a new corporate website that could accurately represent their firm while ensuring absolute, watertight compliance with complex Securities and Exchange Commission (SEC) regulations.
Brand independence following MBO
The challenge: Originally a Freiburg-based German business acquired and absorbed into the Aldevron brand, Genovac faced a pivotal transition following the sale of its parent company. Backed by Aldevron founders Michael Chambers and John Ballantyne, the division executed a successful management buyout (MBO). Under the leadership of new CEO Brian, the immediate challenge was to relaunch Genovac as a standalone US/EU business. Similar to our work with Agathos and Calviri, the core hurdle was translating the immense complexities of their scientific offering into a clear, compelling narrative that would quickly build trust and establish their independent market value.
Launching a specialist healthcare investment firm
The challenge: When launching a high-profile, specialist healthcare private equity firm, trust and timing are everything. We had previously built a strong relationship with Lara Mott during our work with Oxford Biomedica (OXB) and later Circassia. When Lara became the Director of Communications at the newly formed GHO Capital (Global Healthcare Opportunities), she brought thinkerdoer on board based on that proven track record. Operating on an incredibly tight timeline leading up to their launch, GHO Capital needed a brand presence that felt authoritative from day one. The main hurdle was delivering a digital platform that was strictly compliant with UK financial services regulations while clearly communicating their intent to build a premier, transatlantic healthcare-focused investment firm.
Scaling a brand for massive growth
The challenge: Horizon Discovery was on a massive growth trajectory, requiring a brand presence that could keep pace with their rapid expansion. The company faced a unique, dual challenge: they needed to effectively communicate highly complex scientific capabilities, but they had to balance this with an accessible, volume-driven sales marketing look and feel. Ultimately, they needed to visually and verbally step up, positioning themselves not just as a scientific innovator, but as an established, global market leader.
Naming and launching a med-tech startup
The challenge: Continuing a highly successful, multi-company partnership, Lara Mott brought thinkerdoer on board after leaving GHO Capital to co-found a brand-new med-tech startup. The company had a clear, ambitious mission: to drive grassroots efficiency and improve staff engagement within massive, complex healthcare organizations like the NHS. The primary hurdle? They were starting from an absolute blank slate. The company needed a name, a visual identity, and a compelling story to effectively take their innovative platform to market.
Refreshing a visual identity and launching a global brand hub
The challenge: After our successful partnership at Laing O’Rourke, former Comms Director Philip Pashley and production expert Doug Bond moved to Keltbray and immediately re-engaged us. Keltbray needed to modernize its visual identity and completely overhaul its bid production document suite. The core challenge wasn’t just updating the aesthetic; it was solving a logistical hurdle. They needed a highly functional way to ensure that remote teams, working on complex projects from various locations, had immediate and consistent access to the latest brand assets and pitch templates.
Reawakening a dormant brand for IPO and acquisition
The challenge: Verona Pharma had been dormant and required a complete revitalization. Embarking on a highly ambitious journey toward an IPO and an eventual successful sale, the company needed a brand story and visual presence that could match its renewed commercial potential. Working directly with the CEO and FD, the core challenge was not only crafting this new narrative but also presenting regularly to the board to secure absolute buy-in for a radical repositioning. They needed to transform a sleeping business into a highly attractive, market-ready investment opportunity.
Scaling Next-Gen CNC Software
The challenge: For emerging tech startups, having a brilliant product is only half the battle. The founders behind Mattersmith had developed a disruptive software solution designed to help CNC shops bridge the gap from traditional, one-size-fits-all inventory to the next wave of customized production, seamlessly handling everything from infinite-option cutting instructions to complex ordering and billing. However, like many founders setting out for the first time, they possessed deep, specialized industry knowledge but lacked the overarching blueprint required to successfully scale a business, launch the brand, and confidently take their platform to the wider market.
Launching a specialized startup
The challenge: When Stuart Naylor, the former Chief Scientific Officer of our long-term client Oxford Biomedica, left to join a new startup called MeiraGTx, he immediately brought thinkerdoer on board. The challenge was to take this highly specialized new venture and quickly get it off the ground, requiring a foundational brand presence that felt established, cohesive, and ready for rapid growth from day one.
Launching a brand for IPO
The challenge: As a new startup preparing for a high-stakes Initial Public Offering (IPO), Mereo Biopharma needed to rapidly establish a credible, market-ready presence. The core challenge was building a foundational corporate brand from scratch that would immediately instill trust and confidence in potential investors and stakeholders during their critical path to the public market.
Executing a complete brand transformation
The challenge: To stay competitive and accurately reflect their evolving corporate narrative, Proteome required a comprehensive brand transformation. The challenge was to move beyond a simple visual update and deliver a cohesive, modernized identity that could be consistently applied across all of their high-value corporate and digital touchpoints, from daily online interactions to critical stakeholder reporting.
Launching a powerful reinsurance analytics brand
The challenge: TigerEye, a highly valuable analytics asset owned by Howden Re, provides the sophisticated data modeling required to help the reinsurance industry predict and evaluate the risk of complex weather events like hurricanes. The challenge was building a brand presence from scratch that could effectively communicate its market-leading risk structuring capabilities and real-time portfolio analytics to a highly technical audience of global underwriters, analysts, and fund managers.















